Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1β, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis

被引:0
|
作者
El-Shabrawi, Y [1 ]
Christen, WG [1 ]
Foster, CS [1 ]
机构
[1] Massachusetts Eye & Ear Infirm, Immunol & Uveitis Serv, Boston, MA 02114 USA
关键词
uveitis; matrix metalloproteinases; interleukin-1; beta; interleukin-1 receptor antagonists; interleukin-12; proinflammatory cytokines; human;
D O I
10.1076/0271-3683(200003)20:3;1-9;FT211
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. Matrix metalloproteinases have been shown to play a role in active uveitis. Transcription of MMPs is induced by a number of growth factors and cytokines. This study investigates the role of MMPs in chronic uveitis and correlates the amounts of MMP-2 and -9 in intraocular samples to the intraocular levels of proinflammatory cytokines (Interleukin-1 [IL-1], Interleukin-12 [IL-12] and Interleukin-1 receptor antagonist [IL-1ra]). Methods. Aqueous humor of 16 patients was collected during surgical or diagnostic procedures (control group: cataract patients). MMP-2 and -9 were measured using zymography. IL-1, IL-12 and IL-1ra were evaluated by ELISA. Results. We found MMP-2 and -9 in all of our uveitis patients. In the control group only MMP-2 was seen. Higher levels of MMP-2 and -9 were found in patients with higher activity of uveitis (p < 0.014 for MMP-2, p < 0.0054 for MMP-9). The amounts of IL-1, IL-12 and IL-1ra detected in our uveitis patients correlated with levels of MMP-2 (p < 0.07, p < 0.0004, p < 0.03) and MMP-9 (p < 0.003, p < 0.0001, p < 0.002), and IL-12 (p < 0.004, p < 0.0001). Patients with moderately active uveitis presented with twice the level of MMP-2 as the control group; MMP-9 levels reached up to 92% of the amounts found in patients with active uveitis. Two patients in remission for almost one year still had detectable intraocular MMP-9 levels. Conclusion. Our data suggests that the high levels of MMPs found in patients with chronic uveitis might contribute to the damage often seen in these eyes. Since MMPs are capable of releasing proinflammatory cytokines bound to components of the extracellular matrix, and facilitate the secretion of active TNF-alpha by cleavage of the membrane bound form, it is conceivable that MMPs contribute to the chronicity of some uveitis cases.
引用
收藏
页码:211 / 214
页数:4
相关论文
共 50 条
  • [21] EFFECTS OF INTERLEUKIN-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN AIDS-KAPOSIS SARCOMA
    LOUIE, S
    CAI, J
    LAW, R
    LIN, G
    LUNARDIISKANDAR, Y
    JUNG, B
    MASOOD, R
    GILL, P
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 8 (05): : 455 - 460
  • [22] INTERLEUKIN-1 RECEPTOR ANTAGONIST - AN INDEX OF DIALYSIS-INDUCED INTERLEUKIN-1 PRODUCTION
    PEREIRA, BJG
    KING, AJ
    FALAGAS, ME
    DINARELLO, CA
    NEPHRON, 1994, 67 (03): : 358 - 361
  • [23] Human interleukin-1β and interleukin-1 receptor antagonist secretion and velocity of tooth movement
    Iwasaki, LR
    Haack, JE
    Nickel, JC
    Reinhardt, RA
    Petro, TM
    ARCHIVES OF ORAL BIOLOGY, 2001, 46 (02) : 185 - 189
  • [24] Interleukin-1 receptors and receptor antagonist in haemodialysis
    Donati, D
    Degiannis, D
    Mazzola, E
    Gastaldi, L
    Raskova, J
    Raska, K
    Camussi, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (01) : 111 - 118
  • [25] Interleukin-1 receptor antagonist exerts agonist activity in the hippocampus independent of the interleukin-1 type I receptor
    Loscher, CE
    Mills, KHG
    Lynch, MA
    JOURNAL OF NEUROIMMUNOLOGY, 2003, 137 (1-2) : 117 - 124
  • [26] Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets
    Hui, Queenie
    Asadi, Ali
    Park, Yoo Jin
    Kieffer, Timothy J.
    Ao, Ziliang
    Warnock, Garth L.
    Marzban, Lucy
    MOLECULAR METABOLISM, 2017, 6 (08): : 833 - 844
  • [27] Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1β synthesis by human neutrophils
    Langereis, J. D.
    Oudijk, E-J. D.
    Schweizer, R. C.
    Lammers, J-W. J.
    Koenderman, L.
    Ulfman, L. H.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (02) : 406 - 415
  • [28] Evaluation of interleukin-1 beta and the ratio of interleukin-1 beta to interleukin-1 receptor antagonist in gingival crevicular fluid during orthodontic canine retraction
    Motyl, Sylwia
    Manfredini, Daniele
    Oruba, Zuzanna
    Bugajska, Jolanta
    Sztefko, Krystyna
    Stos, Wojciech
    Osiewicz, Magdalena
    Loster, Bartlomiej Wincenty
    Lobbezoo, Frank
    DENTAL AND MEDICAL PROBLEMS, 2021, 58 (01) : 47 - 54
  • [29] Interleukin-1 β, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia:: correlation with prognostic parameters
    Hulkkonen, J
    Vilpo, J
    Vilpo, L
    Koski, T
    Hurme, M
    HAEMATOLOGICA, 2000, 85 (06) : 600 - 606
  • [30] The roles of interleukin-1 and interleukin-1 receptor antagonist in antigen-specific immune responses
    Lin, KW
    Chen, SC
    Chang, FH
    Kung, JT
    Hsu, BRS
    Lin, RH
    JOURNAL OF BIOMEDICAL SCIENCE, 2002, 9 (01) : 26 - 33